Home
Conditions
Thyroid Eye Disease

Clinical trial condition

Thyroid Eye Disease

Explore clinical trials studying Thyroid Eye Disease. Study availability and eligibility vary by location and protocol.

50 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Thyroid Eye Disease trial results

Not Yet Recruiting

A Phase III Study of KHN939 in Chinese Patients With Moderate-to-Severe Inactive Thyroid Eye Disease

NCT07720648

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Clinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)

NCT07623837

Conditions: Autoimmune Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations: 3003 North First Street #221 San Jose, California, United States

View Trial Details

Not Yet Recruiting

An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)

NCT07462130

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease

NCT07308964

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease

NCT07265258

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

NCT07155668

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: United Medical Research Institute Inglewood, California, United States

C&A Clinical Trials Corp Cape Coral, Florida, United States

Ilumina Medical Research Kissimmee, Florida, United States

Med-Care Research Miami, Florida, United States

View all 13 locations

View Trial Details

Completed

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

NCT06367517

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +14 more
Locations: Department of Internal Medicine and Endocrinology, Medical University of Warsaw Warsaw, Poland

View Trial Details

Completed

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

NCT06384547

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: United Medical Research Institute Inglewood, California, United States

Advancing Research International, LLC Los Angeles, California, United States

Stanford Byers Eye Institute Palo Alto, California, United States

Cockerham Eye Consultants, PC San Diego, California, United States

View all 50 locations

View Trial Details

Completed

An Open-label Study (OLE) for Non-responders of VRDN-001-101 (NCT05176639) and VRDN-001-301 (NCT06021054)

NCT06179875

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Advancing Research International, LLC Los Angeles, California, United States

USC Eye Institute Los Angeles, California, United States

Advancing Research International, LLC Newport Beach, California, United States

Stanford Byers Eye Institute Palo Alto, California, United States

View all 45 locations

View Trial Details

Completed

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

NCT05524571

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Site Number -1520 Pasadena, California, United States

Site Number -1517 San Francisco, California, United States

Site Number -1514 Torrance, California, United States

Site Number -1510 Sarasota, Florida, United States

View all 45 locations

View Trial Details

Thyroid Eye Disease

Thyroid Eye Disease trial results

Related conditions